PDS Biotechnology Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PDSB Nasdaq 2830 www.pdsbiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PDS Biotechnology Corporation

PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors - Oct 20th, 2026 6:00 am
PDS Biotechnology Targets Phase III Trial for PDS0301 in Metastatic Colorectal Cancer - Oct 15th, 2026 7:02 pm
PDS Biotechnology (PDSB) Upgraded to Buy: What Does It Mean for the Stock? - Oct 14th, 2026 9:00 am
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases - Oct 6th, 2026 6:00 am
BC-Most Active Stocks - Oct 5th, 2026 8:30 am
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’ - Sep 28th, 2026 8:13 pm
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology - Sep 22nd, 2026 6:00 am
PDS Biotechnology (PDSB) Stock Fair Value Moves Lower After Analyst Cuts And Financing Scrutiny - Sep 18th, 2026 3:12 pm
ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last? - Sep 18th, 2026 1:41 am
This Tiny Biotech Is Beating MRNA, IOVA And SLS — Here's How A Billionaire Fueled Its September Rally - Sep 17th, 2026 1:21 am
IBRX Stock Gains As Soon-Shiong’s Nant Capital Backs Second Cancer-Immunotherapy Bet - Sep 14th, 2026 5:29 pm
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors - Sep 14th, 2026 8:30 am
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks - Sep 8th, 2026 6:30 am
PDS Biotech Reports Second Quarter 2026 Financial Results - Aug 13th, 2026 6:30 am
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101 - Aug 11th, 2026 6:25 am
Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher - Jun 10th, 2026 7:55 am
PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Highlights: Strategic Advancements and ... - May 13th, 2026 5:02 pm
PDS Biotechnology Q1 Earnings Call Highlights - May 13th, 2026 12:09 pm